EASL Podcasts

Talk Liver To Me - Liver Transplantation: Rise of the machines 13.05.2026 37min

In this episode, we discuss the first pig-to-human liver xenotransplantation and the breakthroughs behind the revival of xenotransplantation, examining its potential and remaining challenges. We also explore the accelerating field of machine perfusion, clarifying different approaches and reviewing the evidence supporting their role in organ assessment, optimisation, and DCD utilisation. Host: Sarwa Darwish Murad (Erasmus University Rotterdam) Speakers: Jeroen de Jonge (Erasmus University Rott...

Talk Liver To Me - Spontaneous Bacterial Peritonitis: Time to Rethink the Rules? 29.04.2026 35min

Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis - but rising antimicrobial resistance and emerging data are challenging long-standing practices. In this episode, we review current evidence on primary and secondary prophylaxis, resistance patterns, albumin use, and treatment strategies. How should clinicians balance prevention with antimicrobial stewardship? And where might practice need to evolve in 2026? Host: Thomas Marjot (King's College London) Speakers:&...

EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA) 23.04.2026 1h 7min

In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma. Learning Objectives To identify patients at risk for eCCA, and review the current tools and strategies for its surveillance, diagnosis, staging, and classificationTo define the optimal candidates for resection and liver transplantation, and discuss challenges in the surgic...

Talk Liver To Me - World Liver Day: Making Lifestyle Change Possible 15.04.2026 34min

This episode explores the role of lifestyle in preventing and managing liver disease, including MASLD/MASH. Our experts discuss the impact of diet and physical activity, why lifestyle change can be difficult to start and sustain, and why small, achievable steps can still make a meaningful difference. Host: Cyrielle Caussy Speakers: Kate Hallsworth and Manuel Romero-Gómez This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-07

EASL DeepDive: Key Changes in the New EASL HBV Guidelines 09.04.2026 1h 16min

In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in 2025. Learning objectives Understand the updated EASL recommendations for initiating and discontinuing antiviral therapy in chronic hepatitis B, including key differences with other HBV guidelines. Participants will be able to identify treatment indications and make informed decisions about when a...

EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis 09.04.2026 1h 19min

In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025. Learning objectives Select induction and maintenance treatment strategies aimed at achieving complete biochemical responseRecognise and manage disease flares, treatment intolerance, and suboptimal response in autoimmune hepatitisUnderstand tailored approaches to autoimmune hepatitis management in s...

EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies 09.04.2026 1h 15min

Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, making curative treatment difficult. In this DeepDive Webinar, you’ll be guided through the latest advances in hepatocellular carcinoma management, from the rising impact of immunotherapy combinations to evolving approaches in intermediate-stage disease.&...

Talk Liver To Me - Baveno VIII: The takeaways you shouldn’t miss 01.04.2026 37min

In this episode our speakers share their immediate impressions and break down the key highlights shaping the management of portal hypertension and advanced liver disease. What has truly changed in practice? Where was consensus reached and where do controversies remain? Tune in for a clear, practical overview of what you need to know from Baveno VIII. Host: Thomas Marjot Speakers: Mattias Mandorfer and Cristina Ripoll This episode is also available on EASL Campus: https://easlcampus.eu/t...

Talk Liver To Me - Updated BCLC Guidelines for HCC: Protocolised or Patient-Centred Care? 18.03.2026 29min

This episode unpacks the updated BCLC guidelines for hepatocellular carcinoma management. Experts discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and personalised care, sharing real-world examples of when the algorithm helps and when clinical practice diverges. Host: Mattias Mandorfer Speakers: Marco Sanduzzi, Lorenza Rimassa This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-05

Talk Liver To Me - When Cure isn’t the only goal: Palliative Care in Advanced Liver Disease 04.03.2026 35min

As deaths from advanced chronic liver disease rise, many patients never receive timely palliative care. In this episode, we explore why early, holistic support is essential in advanced liver disease and HCC, and unpack key recommendations from the new EASL Position Paper to help reduce suffering and improve quality of life. Host: Debbie Shawcross Speakers: Patrizia-Künzler-Heule, Sumita Verma This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-04

Talk Liver To Me - MetALD in Practice: Does it Change How We Treat Patients? 18.02.2026 40min

This episode explores whether MetALD is a meaningful clinical entity or an unnecessary complication. Experts discuss the overlap between metabolic dysfunction and alcohol use, the challenges of applying the MetALD definition in practice, and its impact on classification, guidelines, drug development, and patient care. Host: Thomas Marjot Speakers: Mary Rinella , Aleksander Krag This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-03

Talk Liver To Me - From imposter syndrome to influence: Women shaping hepatology 04.02.2026 36min

EASL’s Secretary General and Vice Secretary General share an open conversation on the challenges and opportunities for women in hepatology. The episode explores the role of mentorship across career stages and reflects on the journey toward EASL’s first female Secretary General, offering insights on leadership and change in the field. Host: Maja Thiele Speakers: Debbie Shawcross, Ana Lleo This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-02

Talk Liver To Me - Hepatology Ward Rounds: East Meets West 21.01.2026 36min

In collaboration with the Indian National Association for the Study of the Liver (INASL), hepatologists from South Asia and North America/Europe take listeners inside their liver wards to explore how regional context shapes acute liver care. From admission patterns to alcohol use, infections, DILI, nutrition, and access to transplant, the episode highlights key differences and opportunities for shared learning across regions. This episode is also available on EASL Campus: https://easlcampus.e...

EASL Studio Podcast: Collaborating across disciplines to find the best solution for people living with PBC 18.12.2025 33min

This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC). Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways. Moderator: David Jones Speakers: Marco Carbone, Bettina Hansen, and Ana Lleo All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Vide...

EASL Studio Podcast: What Can Be Done to Safeguard Young Adults from SLD? 11.12.2025 40min

How can we protect young adults from steatotic liver disease (SLD)? This episode explores the burden of MASLD, MetALD, and ALD in Europe, the synergistic effects of alcohol and metabolic risk factors, and why the younger population is especially vulnerable. Experts also examine the disparities in risk factors and the role of clinics and policymakers in prevention. Moderator: Shira Zelber Sagi Speakers: Carina Ferreira-Borges (WHO representative) and Zobair Younossi This EASL Studio is support...

EASL Studio Podcast: Decoding AASLD The Liver Meeting: Trends Shaping Hepatology 04.12.2025 35min

What were the key takeaways from this year’s AASLD The Liver Meeting? In this episode, experts unpack the most impactful studies, clinical insights, and emerging trends shaping the future of hepatology. From liver cancer breakthroughs to MASLD, ALD, and beyond. Moderator: Debbie Shawcross Speakers: Saul Karpen, Allison Kwong, Mazen Noureddin All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Video Podcasts on Apple Podcasts.

EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance 27.11.2025 36min

For World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance. Moderator: Debbie Shawcross Speakers: Rajiv Jalan, Vishal Patel, Jonel Trebicka All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Video Podcasts on Apple Podcasts. This EASL Studio is supported by Alfasigma and Norgine....

EASL Studio Podcast: Behind the Decision: How Can You Maximize Your Chances of Publication in JHEP Reports? 13.11.2025 31min

Ever wondered what happens to your manuscript after submission? In this episode, the JHEP Reports editorial team takes you behind the scenes: from first triage to reviewer selection, smart moves vs. red flags, and how final decisions are made. The discussion also explores the potential, limitations, and ethical pitfalls. Moderator: Mattias Mandorfer Speakers: Tobias Böttler, Virginia Hernández-Gea, Josep Llovet All EASL Studio Podcasts are available on EASL Campus. Click here to see all...

EASL Studio Podcast: Are we finally entering an era of effective treatment for PSC? 06.11.2025 42min

After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode, experts review emerging data and explore whether we’re approaching a new era of effective treatment. How should clinicians assess these therapies, and could they shift the current management of PSC? Moderator: Debbie Shawcross Speakers: Cynthia Levy, Stephen Rossi, Michael Trauner All EASL Studio Podcasts are available on EASL Campus. Click here to see all EAS...

EASL Studio Podcast: Does it really matter whether we call it ACLF or acute decompensation? 09.10.2025 31min

This episode questions whether assigning the label “ACLF” to a deteriorating patient truly alters clinical decisions, or if focusing on the specifics of organ failure and reversibility is more useful. Experts debate the real-world utility of prognostic scores, the clarity (or confusion) created by multiple definitions, and whether the ACLF concept drives urgency, facilitates transplant access, or improves outcomes. A thought-provoking look at where terminology meets bedside care. Moderator: T...